Respi4Doctors est une plate-forme numérique via laquelle AstraZeneca offre des informations et des services en rapport avec le traitement des troubles respiratoires.
Impact of treatment with aclidinium/formoterol on physical activity
Regular physical activity decreases the risk of mortality and hospital admissions among COPD patients1. Hence, maintaining or increasing physical activity is a key objective of COPD management2.
A recent study evaluated the impact of treatment with aclidinium/formoterol on physical activity3. This slide kit provides more details on this recent publication in the International Journal of COPD.
References:
1. Garcia-Aymerich et al., Thorax. 2006; 61: 772-778 - 2. GOLD, Edition 2014 - 3. Watz et al., Int J of COPD. 2017; 12: 2545-58
Preview
Scroll here
